Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

NCT00003388

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Raritan Bay Medical Center Perth Amboy, New Jersey, United States
  • Albert Einstein Comprehensive Cancer Center The Bronx, New York, United States
View Trial Details
Completed

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

NCT00217425

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • California Cancer Care, Incorporated - Greenbrae Greenbrae, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
View all 110 locations
View Trial Details
Completed

A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT02760485

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
  • LAC-USC Medical Center/Kenneth Norris Jr Cancer Hospital Los Angeles, California, United States
View all 21 locations
View Trial Details
Completed

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003615

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • CCOP - Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States
  • Trinitas Hospital - Jersey Street Campus Elizabeth, New Jersey, United States
View Trial Details
Completed

KN046 in Subjects With Advanced Solid Tumors and Lymphoma

NCT03733951

Conditions
Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 13 locations
View Trial Details
Completed

Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas

NCT03311412

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details

Related conditions